Philip Seeman - Publications, H-index & Citations

Philip Seeman

university of toronto

97H指数

441论文数

4.3W被引数

收录论文 71

发表时间

The High Affinity Dopamine D2 Receptor Agonist MCL-536: A New Tool for Studying Dopaminergic Contribution to Neurological Disorders

ACS CHEMICAL NEUROSCIENCE

IF3.9

2021-04-12

OAAI

Subburaju, Sivan; Sromek, Anna W.; Seeman, Philip; Neumeyer, John L.

Oleh Hornykiewicz-In Memoriam

NEUROPSYCHOPHARMACOLOGY

IF7.1

2020-08-20

OAAI

Seeman, Philip

New Dopamine D2 Receptor Agonist, [3H]MCL-536, for Detecting Dopamine D2high Receptors in Vivo

ACS CHEMICAL NEUROSCIENCE

IF3.9

2018-04-11

OAAI

Subburaju, Sivan; Sromek, Anna W.; Seeman, Philip; Neumeyer, John L.

Structural Investigation of the Dopamine-2 Receptor Agonist Bromocriptine Binding to Dimeric D2HighR and D2LowR States

JOURNAL OF CHEMICAL INFORMATION AND MODELING

IF5.3

2018-03-14

OAAI

Salmas, Ramin Ekhteiari; Seeman, Philip; Stein, Matthias; Durdagi, Serdar

Atypical antipsychotics, cortical D2 receptors and sensitivity to endogenous dopamine

BRITISH JOURNAL OF PSYCHIATRY

IF7.6

2018-01-02

OAAI

Kapur, S; Seeman, P

Analysis of the Glutamate Agonist LY404,039 Binding to Nonstatic Dopamine Receptor D2 Dimer Structures and Consensus Docking

ACS CHEMICAL NEUROSCIENCE

IF3.9

2017-03-22

OAAI

Salmas, Ramin Ekhteiari; Seeman, Philip; Aksoydan, Busecan; Erol, Ismail; Kantarcioglu, Isik; Stein, Matthias; Yurtsever, Mine; Durdagi, Serdar

Biological Insights of the Dopaminergic Stabilizer ACR16 at the Binding Pocket of Dopamine D2 Receptor

ACS CHEMICAL NEUROSCIENCE

IF3.9

2017-01-20

PREAI

Salmas, Ramin Ekhteiari; Seeman, Philip; Aksoydan, Busecan; Stein, Matthias; Yurtsever, Mine; Durdagi, Serdar

Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose

TRANSLATIONAL PSYCHIATRY

IF6.2

2016-10-18

131

OAAI

Seeman, P.

Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits

MOLECULAR PSYCHIATRY

IF10.1

2016-01-12

OAAI

Trossbach, S. V.; Bader, V.; Hecher, L.; Pum, M. E.; Masoud, S. T.; Prikulis, I.; Schaeble, S.; Silva, M. A. de Souza; Su, P.; Boulat, B.; Chwiesko, C.; Poschmann, G.; Stuehler, K.; Lohr, K. M.; Stout, K. A.; Oskamp, A.; Godsave, S. F.; Mueller-Schiffmann, A.; Bilzer, T.; Steiner, H.; Peters, P. J.; Bauer, A.; Sauvage, M.; Ramsey, A. J.; Miller, G. W.; Liu, F.; Seeman, P.; Brandon, N. J.; Huston, J. P.; Korth, C.

Binding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques

ACS CHEMICAL NEUROSCIENCE

IF3.9

2015-12-22

PREAI

Durdagi, Serdar; Salmas, Ramin Ekhteiari; Stein, Matthias; Yurtsever, Mine; Seeman, Philip

Therapeutic occupation of dopamine D2 antipsychotic receptors in Alzheimer's disease

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

IF2.8

2014-09-25

PREAI

Seeman, Philip

Depression treatment by withdrawal of short-term low-dose antipsychotic, a proof-of-concept randomized double-blind study

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2014-09-01

PREAI

Kennedy, Sidney H.; Giacobbe, Peter; Placenza, Franca; Hudson, Craig J.; Seeman, Philip; Seeman, Mary V.

18F-MCL-524, an 18F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2014-05-01

OAAI

Finnema, Sjoerd J.; Stepanov, Vladimir; Nakao, Ryuji; Sromek, Anna W.; Zhang, Tangzhi; Neumeyer, John L.; George, Susan R.; Seeman, Philip; Stabin, Michael G.; Jonsson, Cathrine; Farde, Lars; Halldin, Christer

Is schizophrenia a dopamine supersensitivity psychotic reaction?

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

IF3.9

2014-01-01

OAAI

Seeman, Mary V.; Seeman, Philip

Clozapine, a Fast-Off-D2 Antipsychotic

ACS CHEMICAL NEUROSCIENCE

IF3.9

2013-11-18

OAAI

Seeman, Philip